ER stress operates as a driver of disease progression in neurodegenerative diseases.
The UPR modulates ER stress to induce cell adaptation or apoptosis.
AAV-mediated gene therapy is emerging as an alternative to treat diseases.
Modulating the UPR has protective effects in preclinical models of neurodegeneration.